Mol Microbiol 2007,63(4):1096–1106 PubMedCrossRef 14 Plinke C, R

Mol Microbiol 2007,63(4):1096–1106.PubMedCrossRef 14. Plinke C, Rüsch-Gerdes S, Niemann S: Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2006,50(5):1900–1902.PubMedCentralPubMedCrossRef 15. Ramaswamy S, Musser JM: Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis : 1998 update. Tuber Lung Dis 1998,79(1):3–29.PubMedCrossRef 16. Plinke C, Cox H, Zarkua N, Karimovich H, Braker K, Diel R, Rüsch-Gerdes S, Feuerriegel S, Niemann S: embCAB sequence variation among

ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation. JSH-23 manufacturer J Antimicrob Chemother 2010, 65:1359–1367.PubMedCrossRef 17. Jadaun GPS, Das R, Prashant U, Chauhan DS, Charma VD, Katoch VM: Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India. Int J Antimicrob NCT-501 in vivo Agents 2009, 33:483–486.PubMedCrossRef 18. Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PE, Fonseca Lde S, Ho JL, Kritski AL, Rossetti ML: Correlations

of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol 2009, 9:39.PubMedCentralPubMedCrossRef next 19. Dolgin E: African networks launch to boost clinical trial capacity. Nat Med 2010,16(1):8.PubMedCrossRef 20. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA: Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control CB-839 manufacturer programmes. Bull World Health Organ 1969,41(1):21–43.PubMedCentralPubMed 21. Homolka S, Meyer CG, Hillemann D, Owusu-Dabo E, Adjei O, Horstmann RD, Browne EN,

Chinbuah A, Osei I, Gyapong J, Kubica T, Ruesch-Gerdes S, Niemann S: Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana. Int J Med Microbiol 2010,300(7):489–495.PubMedCrossRef 22. Sreevatsan S, Stockbauer KE, Pan X, Kreiswirth BN, Moghazeh SL, Jacobs WR Jr, Telenti A, Musser JM: Ethambutol resistance in Mycobacterium tuberculosis : critical role of embB mutations. Antimicrob Agents Chemother 1997,41(8):1677–1681.PubMedCentralPubMed 23. Srivastavaa S, Ayyagaria A, Dholea TN, Nyatia KK, Dwivedi SK: Emb nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutol. Int J Med Microbiol 2009, 299:269–280.CrossRef 24.

Comments are closed.